Eupraxia Pharmaceuticals (EPRX) Operating Leases (2022 - 2026)
Eupraxia Pharmaceuticals (EPRX) posted quarterly Operating Leases of $1.8 million for Q1 2026, up 2275.57% quarter-over-quarter from $75910.0 in Q4 2025.
Eupraxia Pharmaceuticals (EPRX) Operating Leases (2022 - 2026) Analysis & Trends
Eupraxia Pharmaceuticals (EPRX) has reported Operating Leases for 5 consecutive years, with $1.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Leases changed N/A year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (changed N/A YoY), while the FY2025 annual figure was $75910.0, up 5.64% from the prior year.
- Operating Leases improved to $1.8 million in Q1 2026 per EPRX's latest filing, from $75910.0 in the prior quarter.
- Across five years, Operating Leases topped out at $1.8 million in Q1 2026 and bottomed at $37848.0 in Q1 2024.
- Historically, Operating Leases has averaged $259750.6 across 5 years, with a median of $71859.0 in 2024.
- Annual changes were most pronounced in 2023 — Operating Leases gained 3.92% — and 2024, when it soared 34.78%.
- Eupraxia Pharmaceuticals' Operating Leases stood at $51303.0 in 2022, then rose by 3.92% to $53316.0 in 2023, then soared by 34.78% to $71859.0 in 2024, then grew by 5.64% to $75910.0 in 2025, then jumped by 2275.57% to $1.8 million in 2026.
- Business Quant data shows EPRX's Operating Leases at $1.8 million in Q1 2026, $75910.0 in Q4 2025, and $94467.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Eupraxia Pharmaceuticals | 381.11 Mn | 379.51 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.80 Mn |
| Dec 31, 2025 | 75,910.00 |
| Sep 30, 2025 | 94,467.00 |
| Dec 31, 2024 | 71,859.00 |
| Sep 30, 2024 | 78,752.00 |
| Jun 30, 2024 | 71,008.00 |
| Mar 31, 2024 | 37,848.00 |
| Dec 31, 2023 | 53,316.00 |
| Dec 31, 2022 | 51,303.00 |